Genitourinary Multidisciplinary Clinic
Lifespan Cancer Institute

Genitourinary Cancer Conditions

The Genitourinary Multidisciplinary Clinic provides care ranging from the screening of high-risk individuals, to the most innovative treatments, including advanced radiation oncology services, surgical options and access to investigational therapies. 

Conditions We Treat

  • Prostate cancer, the most common cancer among men, is most successfully treated when found early. The American Cancer Society (ACS) reports that more than 90 percent of all prostate cancers are discovered while they are either localized (confined to the prostate) or regional (nearby). The ACS has stated that in the past 25 years the five-year survival rate for all stages combined has increased from 68 to nearly 100 percent. Learn more about prostate cancer »

  • Bladder cancer is diagnosed when there are abnormal, cancerous cells growing in the bladder. Bladder cancer affects men about three times more often than women. The risk of bladder cancer increases with age—more than 90 percent of people diagnosed with it are older than 55. There are several kinds of bladder cancer. Learn more about bladder cancer »

  • Kidney cancer begins in the kidneys. It may also be referred to as renal cancer. The most common type is called renal cell cancer.

  • Penile cancer is a malignant growth found on the skin or in the tissues of the penis. Around 95% of penile cancers are squamous cell carcinomas. Other types of penile cancer such as merkel cell carcinoma, small cell carcinoma, melanoma and others are rare.

  • Testicular cancer develops in a testicle, the male sex glands that are part of the male reproductive system. It is one of the most curable forms of cancer. Learn more about testicular cancer »

  • Ureter cancer is cancer of the ureters, the muscular tubes that propel urine from the kidneys to the urinary bladder. Ureteral cancer is usually transitional cell carcinoma. Transitional cell carcinoma is a common cause of ureter cancer and other urinary (renal pelvic) tract cancers.